TELA (TELA Bio) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TELA TELA Bio Inc TELA
59 GF Score
Price $1.36
GF Value $1.40
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is TELA Bio Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TELA vs ARAY, MODD, NSYS: Short Interest Comparison

For the Medical Devices subindustry, TELA Bio's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TELA Bio Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, TELA Bio's Short Interest distribution charts can be found below:

* The bar in red indicates where TELA Bio's Short Interest falls into.


TELA
59GF Score
TELA Bio Inc TELA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is TELA Bio (TELA) Overvalued in 2026?

Based on GuruFocus' analysis, TELA Bio stock appears to be undervalued. The current stock price of $1.36 is trading 2.9% below its estimated GF Value™ of $1.40. GuruFocus considers TELA Bio to be Fairly Valued.

Key valuation signals for TELA:

  • Short Interest:
  • GF Value™: $1.40 vs. price of $1.36 (2.9% below fair value)
  • GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the TELA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TELA Bio Business Description

Address 1 Great Valley Parkway, Suite 24, Malvern, PA, USA, 19355
TELA Bio Inc. is a commercial-stage medical technology company based in the United States that develops soft-tissue reconstruction solutions for hernia repair and abdominal wall reconstruction. Its main product line, the OviTex portfolio, includes multiple configurations of reinforced biologic matrices designed to support the patient's natural healing response while reducing long-term exposure to permanent synthetic materials. These products address ventral, inguinal, and hiatal hernia repair as well as abdominal wall reconstruction. The company also offers OviTex PRS for plastic and reconstructive surgery. TELA Bio sells primarily to hospitals, surgeons, and healthcare providers in the United States, generating revenue through direct sales of its products. Its products are intended to offer alternatives to conventional synthetic and biologic meshes by combining biologic tissue with a resorbable polymer reinforcement.
59GF Score

Get the complete analysis for TELA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.36
Price
$1.40
GF Value